nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—CXCL8—uterine cancer	0.585	1	CbGaD
Tolmetin—MPO—Carboplatin—uterine cancer	0.166	0.652	CbGbCtD
Tolmetin—PTGS2—Etoposide—uterine cancer	0.0481	0.189	CbGbCtD
Tolmetin—PTGS1—Etoposide—uterine cancer	0.0406	0.16	CbGbCtD
Tolmetin—MPO—artery—uterine cancer	0.00346	0.0793	CbGeAlD
Tolmetin—TDO2—female reproductive system—uterine cancer	0.00303	0.0694	CbGeAlD
Tolmetin—CXCL8—myometrium—uterine cancer	0.00286	0.0655	CbGeAlD
Tolmetin—PTGS1—oviduct—uterine cancer	0.00248	0.0568	CbGeAlD
Tolmetin—CXCL8—uterine cervix—uterine cancer	0.00223	0.051	CbGeAlD
Tolmetin—CXCL8—smooth muscle tissue—uterine cancer	0.00216	0.0496	CbGeAlD
Tolmetin—CXCL8—decidua—uterine cancer	0.00212	0.0486	CbGeAlD
Tolmetin—CXCL8—endometrium—uterine cancer	0.00201	0.0461	CbGeAlD
Tolmetin—TDO2—lymph node—uterine cancer	0.00177	0.0406	CbGeAlD
Tolmetin—PTGS1—artery—uterine cancer	0.00164	0.0376	CbGeAlD
Tolmetin—PTGS2—artery—uterine cancer	0.00157	0.036	CbGeAlD
Tolmetin—CXCL8—female gonad—uterine cancer	0.00152	0.0348	CbGeAlD
Tolmetin—CXCL8—vagina—uterine cancer	0.00151	0.0346	CbGeAlD
Tolmetin—Indomethacin—AKR1C3—uterine cancer	0.00144	0.625	CrCbGaD
Tolmetin—Proteinuria—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.0194	CcSEcCtD
Tolmetin—Protein urine present—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.0192	CcSEcCtD
Tolmetin—Blood pressure increased—Progesterone—uterine cancer	0.00133	0.0188	CcSEcCtD
Tolmetin—MPO—epithelium—uterine cancer	0.00131	0.0301	CbGeAlD
Tolmetin—MPO—renal system—uterine cancer	0.00122	0.0279	CbGeAlD
Tolmetin—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.0171	CcSEcCtD
Tolmetin—Lymphadenopathy—Progesterone—uterine cancer	0.00114	0.016	CcSEcCtD
Tolmetin—Vascular purpura—Progesterone—uterine cancer	0.00108	0.0153	CcSEcCtD
Tolmetin—Visual disturbance—Progesterone—uterine cancer	0.00102	0.0144	CcSEcCtD
Tolmetin—Purpura—Progesterone—uterine cancer	0.00101	0.0142	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Progesterone—uterine cancer	0.001	0.0141	CcSEcCtD
Tolmetin—CXCL8—lymph node—uterine cancer	0.000976	0.0224	CbGeAlD
Tolmetin—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000973	0.0137	CcSEcCtD
Tolmetin—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.000968	0.0137	CcSEcCtD
Tolmetin—Visual disturbance—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.0131	CcSEcCtD
Tolmetin—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.000911	0.0129	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000907	0.0128	CcSEcCtD
Tolmetin—Indomethacin—CXCL8—uterine cancer	0.000868	0.375	CrCbGaD
Tolmetin—Gastritis—Progesterone—uterine cancer	0.000857	0.0121	CcSEcCtD
Tolmetin—Abdominal discomfort—Progesterone—uterine cancer	0.000803	0.0113	CcSEcCtD
Tolmetin—Dysuria—Progesterone—uterine cancer	0.000783	0.011	CcSEcCtD
Tolmetin—Weight increased—Progesterone—uterine cancer	0.000762	0.0108	CcSEcCtD
Tolmetin—PTGS2—myometrium—uterine cancer	0.000759	0.0174	CbGeAlD
Tolmetin—Weight decreased—Progesterone—uterine cancer	0.000758	0.0107	CcSEcCtD
Tolmetin—Drowsiness—Progesterone—uterine cancer	0.000747	0.0105	CcSEcCtD
Tolmetin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.0103	CcSEcCtD
Tolmetin—Urinary tract infection—Progesterone—uterine cancer	0.000726	0.0102	CcSEcCtD
Tolmetin—Body temperature increased—Carboplatin—uterine cancer	0.000717	0.0101	CcSEcCtD
Tolmetin—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00071	0.01	CcSEcCtD
Tolmetin—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.000691	0.00974	CcSEcCtD
Tolmetin—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.000687	0.00968	CcSEcCtD
Tolmetin—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00954	CcSEcCtD
Tolmetin—Hepatitis—Progesterone—uterine cancer	0.00067	0.00946	CcSEcCtD
Tolmetin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.0093	CcSEcCtD
Tolmetin—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00928	CcSEcCtD
Tolmetin—Visual impairment—Progesterone—uterine cancer	0.000646	0.00911	CcSEcCtD
Tolmetin—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.000638	0.009	CcSEcCtD
Tolmetin—Erythema multiforme—Progesterone—uterine cancer	0.000634	0.00894	CcSEcCtD
Tolmetin—Tinnitus—Progesterone—uterine cancer	0.000625	0.00882	CcSEcCtD
Tolmetin—PTGS1—epithelium—uterine cancer	0.000623	0.0143	CbGeAlD
Tolmetin—PTGS1—uterine cervix—uterine cancer	0.000618	0.0141	CbGeAlD
Tolmetin—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.000617	0.0087	CcSEcCtD
Tolmetin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00857	CcSEcCtD
Tolmetin—PTGS1—smooth muscle tissue—uterine cancer	0.000601	0.0137	CbGeAlD
Tolmetin—PTGS2—epithelium—uterine cancer	0.000596	0.0136	CbGeAlD
Tolmetin—PTGS2—uterine cervix—uterine cancer	0.000591	0.0135	CbGeAlD
Tolmetin—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000585	0.00826	CcSEcCtD
Tolmetin—PTGS1—renal system—uterine cancer	0.000578	0.0132	CbGeAlD
Tolmetin—Flatulence—Progesterone—uterine cancer	0.000575	0.00811	CcSEcCtD
Tolmetin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.000574	0.0081	CcSEcCtD
Tolmetin—PTGS2—smooth muscle tissue—uterine cancer	0.000574	0.0131	CbGeAlD
Tolmetin—MPO—lymph node—uterine cancer	0.000571	0.0131	CbGeAlD
Tolmetin—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.000566	0.00799	CcSEcCtD
Tolmetin—PTGS1—endometrium—uterine cancer	0.000559	0.0128	CbGeAlD
Tolmetin—PTGS2—renal system—uterine cancer	0.000553	0.0127	CbGeAlD
Tolmetin—Cardiac failure congestive—Etoposide—uterine cancer	0.000547	0.00771	CcSEcCtD
Tolmetin—PTGS1—mammalian vulva—uterine cancer	0.000541	0.0124	CbGeAlD
Tolmetin—PTGS2—endometrium—uterine cancer	0.000534	0.0122	CbGeAlD
Tolmetin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00735	CcSEcCtD
Tolmetin—PTGS1—uterus—uterine cancer	0.000515	0.0118	CbGeAlD
Tolmetin—Stomatitis—Dactinomycin—uterine cancer	0.000514	0.00726	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Etoposide—uterine cancer	0.000512	0.00722	CcSEcCtD
Tolmetin—Chest pain—Progesterone—uterine cancer	0.000497	0.00701	CcSEcCtD
Tolmetin—Agranulocytosis—Dactinomycin—uterine cancer	0.000493	0.00695	CcSEcCtD
Tolmetin—PTGS2—uterus—uterine cancer	0.000492	0.0113	CbGeAlD
Tolmetin—Anaphylactic shock—Progesterone—uterine cancer	0.000476	0.00672	CcSEcCtD
Tolmetin—Oedema—Progesterone—uterine cancer	0.000476	0.00672	CcSEcCtD
Tolmetin—Hepatitis—Dactinomycin—uterine cancer	0.000474	0.00668	CcSEcCtD
Tolmetin—PTGS1—female reproductive system—uterine cancer	0.000463	0.0106	CbGeAlD
Tolmetin—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00045	0.00635	CcSEcCtD
Tolmetin—Erythema multiforme—Dactinomycin—uterine cancer	0.000448	0.00632	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.000446	0.0063	CcSEcCtD
Tolmetin—PTGS2—female reproductive system—uterine cancer	0.000443	0.0101	CbGeAlD
Tolmetin—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.00609	CcSEcCtD
Tolmetin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000432	0.00609	CcSEcCtD
Tolmetin—Somnolence—Progesterone—uterine cancer	0.000423	0.00597	CcSEcCtD
Tolmetin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.00596	CcSEcCtD
Tolmetin—PTGS1—female gonad—uterine cancer	0.000421	0.00965	CbGeAlD
Tolmetin—Dyspepsia—Progesterone—uterine cancer	0.000419	0.00591	CcSEcCtD
Tolmetin—PTGS1—vagina—uterine cancer	0.000419	0.00959	CbGeAlD
Tolmetin—Glossitis—Epirubicin—uterine cancer	0.000415	0.00586	CcSEcCtD
Tolmetin—Constipation—Progesterone—uterine cancer	0.000407	0.00574	CcSEcCtD
Tolmetin—PTGS2—female gonad—uterine cancer	0.000403	0.00922	CbGeAlD
Tolmetin—PTGS2—vagina—uterine cancer	0.0004	0.00916	CbGeAlD
Tolmetin—Gastrointestinal pain—Progesterone—uterine cancer	0.000389	0.00549	CcSEcCtD
Tolmetin—Glossitis—Doxorubicin—uterine cancer	0.000384	0.00542	CcSEcCtD
Tolmetin—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000384	0.00541	CcSEcCtD
Tolmetin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00536	CcSEcCtD
Tolmetin—Urticaria—Progesterone—uterine cancer	0.000378	0.00534	CcSEcCtD
Tolmetin—Body temperature increased—Progesterone—uterine cancer	0.000376	0.00531	CcSEcCtD
Tolmetin—Abdominal pain—Progesterone—uterine cancer	0.000376	0.00531	CcSEcCtD
Tolmetin—Renal failure—Etoposide—uterine cancer	0.000375	0.0053	CcSEcCtD
Tolmetin—Stomatitis—Etoposide—uterine cancer	0.000372	0.00525	CcSEcCtD
Tolmetin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000369	0.00521	CcSEcCtD
Tolmetin—Blood urea increased—Epirubicin—uterine cancer	0.000361	0.0051	CcSEcCtD
Tolmetin—Agranulocytosis—Etoposide—uterine cancer	0.000356	0.00503	CcSEcCtD
Tolmetin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00498	CcSEcCtD
Tolmetin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000343	0.00484	CcSEcCtD
Tolmetin—Asthenia—Progesterone—uterine cancer	0.000342	0.00482	CcSEcCtD
Tolmetin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000341	0.00481	CcSEcCtD
Tolmetin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000341	0.00481	CcSEcCtD
Tolmetin—Oedema—Dactinomycin—uterine cancer	0.000337	0.00475	CcSEcCtD
Tolmetin—Blood urea increased—Doxorubicin—uterine cancer	0.000334	0.00472	CcSEcCtD
Tolmetin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00033	0.00465	CcSEcCtD
Tolmetin—Diarrhoea—Progesterone—uterine cancer	0.000326	0.0046	CcSEcCtD
Tolmetin—Lymphadenopathy—Epirubicin—uterine cancer	0.000326	0.00459	CcSEcCtD
Tolmetin—Erythema multiforme—Etoposide—uterine cancer	0.000324	0.00457	CcSEcCtD
Tolmetin—Dizziness—Progesterone—uterine cancer	0.000315	0.00444	CcSEcCtD
Tolmetin—Vascular purpura—Epirubicin—uterine cancer	0.000311	0.00438	CcSEcCtD
Tolmetin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00437	CcSEcCtD
Tolmetin—Cardiac failure congestive—Epirubicin—uterine cancer	0.000306	0.00432	CcSEcCtD
Tolmetin—Vomiting—Progesterone—uterine cancer	0.000303	0.00427	CcSEcCtD
Tolmetin—Lymphadenopathy—Doxorubicin—uterine cancer	0.000301	0.00425	CcSEcCtD
Tolmetin—Headache—Progesterone—uterine cancer	0.000298	0.00421	CcSEcCtD
Tolmetin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000295	0.00417	CcSEcCtD
Tolmetin—Purpura—Epirubicin—uterine cancer	0.000288	0.00407	CcSEcCtD
Tolmetin—Vascular purpura—Doxorubicin—uterine cancer	0.000287	0.00405	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000287	0.00405	CcSEcCtD
Tolmetin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00403	CcSEcCtD
Tolmetin—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000283	0.004	CcSEcCtD
Tolmetin—Nausea—Progesterone—uterine cancer	0.000283	0.00399	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000278	0.00392	CcSEcCtD
Tolmetin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000275	0.00388	CcSEcCtD
Tolmetin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000274	0.00387	CcSEcCtD
Tolmetin—PTGS1—lymph node—uterine cancer	0.000271	0.0062	CbGeAlD
Tolmetin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00027	0.00381	CcSEcCtD
Tolmetin—Purpura—Doxorubicin—uterine cancer	0.000267	0.00376	CcSEcCtD
Tolmetin—Abdominal pain—Dactinomycin—uterine cancer	0.000266	0.00375	CcSEcCtD
Tolmetin—Body temperature increased—Dactinomycin—uterine cancer	0.000266	0.00375	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000266	0.00375	CcSEcCtD
Tolmetin—PTGS2—lymph node—uterine cancer	0.000259	0.00593	CbGeAlD
Tolmetin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000257	0.00363	CcSEcCtD
Tolmetin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000256	0.00362	CcSEcCtD
Tolmetin—Chest pain—Etoposide—uterine cancer	0.000254	0.00358	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00025	0.00353	CcSEcCtD
Tolmetin—Gastritis—Epirubicin—uterine cancer	0.000246	0.00347	CcSEcCtD
Tolmetin—Anaphylactic shock—Etoposide—uterine cancer	0.000244	0.00344	CcSEcCtD
Tolmetin—Asthenia—Dactinomycin—uterine cancer	0.000241	0.00341	CcSEcCtD
Tolmetin—Thrombocytopenia—Etoposide—uterine cancer	0.000239	0.00336	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000231	0.00327	CcSEcCtD
Tolmetin—Diarrhoea—Dactinomycin—uterine cancer	0.00023	0.00325	CcSEcCtD
Tolmetin—Gastritis—Doxorubicin—uterine cancer	0.000228	0.00321	CcSEcCtD
Tolmetin—Dysuria—Epirubicin—uterine cancer	0.000225	0.00317	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—HMGA1—uterine cancer	0.000221	0.00504	CbGpPWpGaD
Tolmetin—Weight increased—Epirubicin—uterine cancer	0.000219	0.00308	CcSEcCtD
Tolmetin—Weight decreased—Epirubicin—uterine cancer	0.000217	0.00306	CcSEcCtD
Tolmetin—Somnolence—Etoposide—uterine cancer	0.000217	0.00306	CcSEcCtD
Tolmetin—Drowsiness—Epirubicin—uterine cancer	0.000214	0.00302	CcSEcCtD
Tolmetin—Vomiting—Dactinomycin—uterine cancer	0.000214	0.00302	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—TP53—uterine cancer	0.000211	0.00482	CbGpPWpGaD
Tolmetin—Renal failure—Epirubicin—uterine cancer	0.00021	0.00297	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—EZH2—uterine cancer	0.00021	0.00479	CbGpPWpGaD
Tolmetin—Stomatitis—Epirubicin—uterine cancer	0.000209	0.00294	CcSEcCtD
Tolmetin—Constipation—Etoposide—uterine cancer	0.000208	0.00294	CcSEcCtD
Tolmetin—Urinary tract infection—Epirubicin—uterine cancer	0.000208	0.00294	CcSEcCtD
Tolmetin—CXCL8—Unfolded Protein Response (UPR)—CCL2—uterine cancer	0.000208	0.00475	CbGpPWpGaD
Tolmetin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.000208	0.00474	CbGpPWpGaD
Tolmetin—Dysuria—Doxorubicin—uterine cancer	0.000208	0.00293	CcSEcCtD
Tolmetin—PTGS2—Selenium Micronutrient Network—GPX3—uterine cancer	0.000206	0.0047	CbGpPWpGaD
Tolmetin—Haematuria—Epirubicin—uterine cancer	0.000204	0.00288	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000204	0.00466	CbGpPWpGaD
Tolmetin—Weight increased—Doxorubicin—uterine cancer	0.000202	0.00285	CcSEcCtD
Tolmetin—CXCL8—Bladder Cancer—HRAS—uterine cancer	0.000202	0.00461	CbGpPWpGaD
Tolmetin—Epistaxis—Epirubicin—uterine cancer	0.000202	0.00285	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	0.000201	0.0046	CbGpPWpGaD
Tolmetin—Weight decreased—Doxorubicin—uterine cancer	0.000201	0.00284	CcSEcCtD
Tolmetin—Nausea—Dactinomycin—uterine cancer	0.0002	0.00282	CcSEcCtD
Tolmetin—Agranulocytosis—Epirubicin—uterine cancer	0.0002	0.00282	CcSEcCtD
Tolmetin—Gastrointestinal pain—Etoposide—uterine cancer	0.000199	0.00281	CcSEcCtD
Tolmetin—Drowsiness—Doxorubicin—uterine cancer	0.000198	0.00279	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN2A—uterine cancer	0.000198	0.00452	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine cancer	0.000197	0.00449	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—GPX3—uterine cancer	0.000195	0.00446	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000195	0.00446	CbGpPWpGaD
Tolmetin—Renal failure—Doxorubicin—uterine cancer	0.000195	0.00275	CcSEcCtD
Tolmetin—Urticaria—Etoposide—uterine cancer	0.000194	0.00273	CcSEcCtD
Tolmetin—CXCL8—IL8- and CXCR1-mediated signaling events—AKT1—uterine cancer	0.000193	0.00442	CbGpPWpGaD
Tolmetin—Stomatitis—Doxorubicin—uterine cancer	0.000193	0.00272	CcSEcCtD
Tolmetin—Abdominal pain—Etoposide—uterine cancer	0.000193	0.00272	CcSEcCtD
Tolmetin—Body temperature increased—Etoposide—uterine cancer	0.000193	0.00272	CcSEcCtD
Tolmetin—Urinary tract infection—Doxorubicin—uterine cancer	0.000193	0.00272	CcSEcCtD
Tolmetin—Hepatitis—Epirubicin—uterine cancer	0.000192	0.00271	CcSEcCtD
Tolmetin—Haematuria—Doxorubicin—uterine cancer	0.000189	0.00266	CcSEcCtD
Tolmetin—TDO2—Metabolism—STAR—uterine cancer	0.000187	0.00428	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKR1B1—uterine cancer	0.000187	0.00428	CbGpPWpGaD
Tolmetin—Epistaxis—Doxorubicin—uterine cancer	0.000187	0.00264	CcSEcCtD
Tolmetin—Visual impairment—Epirubicin—uterine cancer	0.000185	0.00261	CcSEcCtD
Tolmetin—Agranulocytosis—Doxorubicin—uterine cancer	0.000185	0.00261	CcSEcCtD
Tolmetin—Erythema multiforme—Epirubicin—uterine cancer	0.000182	0.00256	CcSEcCtD
Tolmetin—PTGS2—S1P1 pathway—VEGFA—uterine cancer	0.000181	0.00414	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—EP300—uterine cancer	0.000179	0.00409	CbGpPWpGaD
Tolmetin—Tinnitus—Epirubicin—uterine cancer	0.000179	0.00253	CcSEcCtD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—HRAS—uterine cancer	0.000179	0.00409	CbGpPWpGaD
Tolmetin—Hepatitis—Doxorubicin—uterine cancer	0.000178	0.00251	CcSEcCtD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	0.000178	0.00406	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—EP300—uterine cancer	0.000176	0.00403	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CDKN1B—uterine cancer	0.000175	0.004	CbGpPWpGaD
Tolmetin—Asthenia—Etoposide—uterine cancer	0.000175	0.00247	CcSEcCtD
Tolmetin—Visual impairment—Doxorubicin—uterine cancer	0.000171	0.00242	CcSEcCtD
Tolmetin—Erythema multiforme—Doxorubicin—uterine cancer	0.000168	0.00237	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—NRAS—uterine cancer	0.000168	0.00383	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—HMGA1—uterine cancer	0.000167	0.00381	CbGpPWpGaD
Tolmetin—Diarrhoea—Etoposide—uterine cancer	0.000167	0.00235	CcSEcCtD
Tolmetin—Tinnitus—Doxorubicin—uterine cancer	0.000166	0.00234	CcSEcCtD
Tolmetin—CXCL8—IL8- and CXCR2-mediated signaling events—AKT1—uterine cancer	0.000166	0.00378	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—CTNNB1—uterine cancer	0.000165	0.00378	CbGpPWpGaD
Tolmetin—Flatulence—Epirubicin—uterine cancer	0.000165	0.00233	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—PTEN—uterine cancer	0.000161	0.00368	CbGpPWpGaD
Tolmetin—Dizziness—Etoposide—uterine cancer	0.000161	0.00227	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—YWHAE—uterine cancer	0.000159	0.00363	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EZH2—uterine cancer	0.000158	0.00362	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—CDKN2B—uterine cancer	0.000158	0.00361	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000158	0.00361	CbGpPWpGaD
Tolmetin—CXCL8—TSLP Signaling Pathway—PIK3CA—uterine cancer	0.000156	0.00357	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TP53—uterine cancer	0.000156	0.00355	CbGpPWpGaD
Tolmetin—Vomiting—Etoposide—uterine cancer	0.000155	0.00218	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—EP300—uterine cancer	0.000154	0.00351	CbGpPWpGaD
Tolmetin—Headache—Etoposide—uterine cancer	0.000153	0.00215	CcSEcCtD
Tolmetin—Flatulence—Doxorubicin—uterine cancer	0.000153	0.00215	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—CCL2—uterine cancer	0.000149	0.00341	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	0.000149	0.0034	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—POLD1—uterine cancer	0.000147	0.00336	CbGpPWpGaD
Tolmetin—Nausea—Etoposide—uterine cancer	0.000145	0.00204	CcSEcCtD
Tolmetin—MPO—C-MYB transcription factor network—KRAS—uterine cancer	0.000144	0.00329	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—uterine cancer	0.000143	0.00326	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—uterine cancer	0.000143	0.00326	CbGpPWpGaD
Tolmetin—Chest pain—Epirubicin—uterine cancer	0.000142	0.00201	CcSEcCtD
Tolmetin—PTGS1—Biological oxidations—CYP11A1—uterine cancer	0.000141	0.00322	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00014	0.0032	CbGpPWpGaD
Tolmetin—CXCL8—IL-3 Signaling Pathway—HRAS—uterine cancer	0.00014	0.0032	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	0.000138	0.00316	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKR1C1—uterine cancer	0.000138	0.00314	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Epirubicin—uterine cancer	0.000137	0.00193	CcSEcCtD
Tolmetin—Oedema—Epirubicin—uterine cancer	0.000137	0.00193	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—EP300—uterine cancer	0.000136	0.00309	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Epirubicin—uterine cancer	0.000134	0.00189	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000133	0.00304	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.000133	0.00304	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—VEGFA—uterine cancer	0.000132	0.00302	CbGpPWpGaD
Tolmetin—Chest pain—Doxorubicin—uterine cancer	0.000132	0.00186	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—AKT1—uterine cancer	0.000128	0.00292	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—uterine cancer	0.000127	0.00289	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—CDKN1B—uterine cancer	0.000127	0.00289	CbGpPWpGaD
Tolmetin—Oedema—Doxorubicin—uterine cancer	0.000126	0.00178	CcSEcCtD
Tolmetin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000126	0.00178	CcSEcCtD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000125	0.00286	CbGpPWpGaD
Tolmetin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000124	0.00175	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—AKT1—uterine cancer	0.000124	0.00282	CbGpPWpGaD
Tolmetin—MPO—C-MYB transcription factor network—HRAS—uterine cancer	0.000123	0.0028	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—RRM2—uterine cancer	0.000123	0.0028	CbGpPWpGaD
Tolmetin—Somnolence—Epirubicin—uterine cancer	0.000121	0.00171	CcSEcCtD
Tolmetin—Dyspepsia—Epirubicin—uterine cancer	0.00012	0.0017	CcSEcCtD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2B—uterine cancer	0.00012	0.00273	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—DCN—uterine cancer	0.000119	0.00272	CbGpPWpGaD
Tolmetin—Constipation—Epirubicin—uterine cancer	0.000117	0.00165	CcSEcCtD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—PTEN—uterine cancer	0.000117	0.00266	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—INHBA—uterine cancer	0.000115	0.00264	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CDKN1B—uterine cancer	0.000115	0.00263	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—HRAS—uterine cancer	0.000113	0.00258	CbGpPWpGaD
Tolmetin—Somnolence—Doxorubicin—uterine cancer	0.000112	0.00158	CcSEcCtD
Tolmetin—TDO2—Metabolism—CYP11A1—uterine cancer	0.000112	0.00256	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000112	0.00158	CcSEcCtD
Tolmetin—Dyspepsia—Doxorubicin—uterine cancer	0.000111	0.00157	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—TP53—uterine cancer	0.00011	0.00251	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—MME—uterine cancer	0.000109	0.00248	CbGpPWpGaD
Tolmetin—Urticaria—Epirubicin—uterine cancer	0.000108	0.00153	CcSEcCtD
Tolmetin—Constipation—Doxorubicin—uterine cancer	0.000108	0.00152	CcSEcCtD
Tolmetin—Abdominal pain—Epirubicin—uterine cancer	0.000108	0.00152	CcSEcCtD
Tolmetin—Body temperature increased—Epirubicin—uterine cancer	0.000108	0.00152	CcSEcCtD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000107	0.00245	CbGpPWpGaD
Tolmetin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.000107	0.00244	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000106	0.00243	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKR1C3—uterine cancer	0.000106	0.00242	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000106	0.00241	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—CCL2—uterine cancer	0.000104	0.00238	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP19A1—uterine cancer	0.000104	0.00237	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000103	0.00146	CcSEcCtD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—uterine cancer	0.000103	0.00235	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CCL2—uterine cancer	0.000102	0.00233	CbGpPWpGaD
Tolmetin—Urticaria—Doxorubicin—uterine cancer	0.0001	0.00142	CcSEcCtD
Tolmetin—Body temperature increased—Doxorubicin—uterine cancer	9.99e-05	0.00141	CcSEcCtD
Tolmetin—Abdominal pain—Doxorubicin—uterine cancer	9.99e-05	0.00141	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—AKT1—uterine cancer	9.98e-05	0.00228	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.93e-05	0.00227	CbGpPWpGaD
Tolmetin—Asthenia—Epirubicin—uterine cancer	9.8e-05	0.00138	CcSEcCtD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—TP53—uterine cancer	9.7e-05	0.00221	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	9.43e-05	0.00215	CbGpPWpGaD
Tolmetin—Diarrhoea—Epirubicin—uterine cancer	9.34e-05	0.00132	CcSEcCtD
Tolmetin—Asthenia—Doxorubicin—uterine cancer	9.07e-05	0.00128	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—CDKN2A—uterine cancer	9.05e-05	0.00207	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.05e-05	0.00207	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.05e-05	0.00207	CbGpPWpGaD
Tolmetin—Dizziness—Epirubicin—uterine cancer	9.03e-05	0.00127	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	8.99e-05	0.00205	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	8.93e-05	0.00204	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	8.82e-05	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	8.72e-05	0.00199	CbGpPWpGaD
Tolmetin—Vomiting—Epirubicin—uterine cancer	8.68e-05	0.00122	CcSEcCtD
Tolmetin—Diarrhoea—Doxorubicin—uterine cancer	8.65e-05	0.00122	CcSEcCtD
Tolmetin—Headache—Epirubicin—uterine cancer	8.55e-05	0.00121	CcSEcCtD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	8.42e-05	0.00192	CbGpPWpGaD
Tolmetin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	8.39e-05	0.00192	CbGpPWpGaD
Tolmetin—Dizziness—Doxorubicin—uterine cancer	8.36e-05	0.00118	CcSEcCtD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	8.34e-05	0.0019	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	8.27e-05	0.00189	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP19A1—uterine cancer	8.25e-05	0.00188	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—STK11—uterine cancer	8.25e-05	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—AKT1—uterine cancer	8.19e-05	0.00187	CbGpPWpGaD
Tolmetin—Nausea—Epirubicin—uterine cancer	8.11e-05	0.00114	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—EP300—uterine cancer	8.1e-05	0.00185	CbGpPWpGaD
Tolmetin—Vomiting—Doxorubicin—uterine cancer	8.03e-05	0.00113	CcSEcCtD
Tolmetin—CXCL8—Cellular Senescence—CDKN1B—uterine cancer	8.01e-05	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TP53—uterine cancer	7.96e-05	0.00182	CbGpPWpGaD
Tolmetin—Headache—Doxorubicin—uterine cancer	7.92e-05	0.00112	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—VEGFA—uterine cancer	7.67e-05	0.00175	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—HRAS—uterine cancer	7.61e-05	0.00174	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	7.59e-05	0.00173	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	7.57e-05	0.00173	CbGpPWpGaD
Tolmetin—Nausea—Doxorubicin—uterine cancer	7.51e-05	0.00106	CcSEcCtD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	7.49e-05	0.00171	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—AKT1—uterine cancer	7.47e-05	0.00171	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TP53—uterine cancer	7.25e-05	0.00165	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.18e-05	0.00164	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.18e-05	0.00164	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—FBXW7—uterine cancer	7.13e-05	0.00163	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	6.88e-05	0.00157	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	6.84e-05	0.00156	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN2A—uterine cancer	6.84e-05	0.00156	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	6.79e-05	0.00155	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.64e-05	0.00152	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	6.63e-05	0.00151	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	6.57e-05	0.0015	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKR1B10—uterine cancer	6.57e-05	0.0015	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	6.54e-05	0.00149	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.45e-05	0.00147	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MTHFR—uterine cancer	6.2e-05	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—CDKN1B—uterine cancer	6.06e-05	0.00138	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	5.82e-05	0.00133	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—NDUFB11—uterine cancer	5.57e-05	0.00127	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SRD5A2—uterine cancer	5.57e-05	0.00127	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	5.45e-05	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RNF43—uterine cancer	5.44e-05	0.00124	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.41e-05	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	5.37e-05	0.00123	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—EP300—uterine cancer	5.32e-05	0.00121	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.27e-05	0.0012	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CCL2—uterine cancer	5.21e-05	0.00119	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	5.17e-05	0.00118	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.11e-05	0.00117	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	5.06e-05	0.00115	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	5.05e-05	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—VEGFA—uterine cancer	5.04e-05	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—TP53—uterine cancer	5.04e-05	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—INHBA—uterine cancer	4.98e-05	0.00114	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	4.69e-05	0.00107	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKR1C1—uterine cancer	4.48e-05	0.00102	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SRD5A2—uterine cancer	4.42e-05	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—NDUFB11—uterine cancer	4.42e-05	0.00101	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.3e-05	0.000981	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKR1B10—uterine cancer	4.11e-05	0.000938	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.06e-05	0.000926	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKR1B1—uterine cancer	4.03e-05	0.00092	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—STAR—uterine cancer	4.03e-05	0.00092	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	3.99e-05	0.00091	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.98e-05	0.000909	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—TP53—uterine cancer	3.81e-05	0.000869	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.71e-05	0.000847	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CCL2—uterine cancer	3.67e-05	0.000837	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKR1C3—uterine cancer	3.45e-05	0.000788	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PTEN—uterine cancer	3.45e-05	0.000787	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.44e-05	0.000785	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RNF43—uterine cancer	3.4e-05	0.000777	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PGR—uterine cancer	3.36e-05	0.000767	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—EP300—uterine cancer	3.29e-05	0.000751	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.25e-05	0.000741	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—YWHAE—uterine cancer	3.21e-05	0.000732	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKR1B1—uterine cancer	3.2e-05	0.00073	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—STAR—uterine cancer	3.2e-05	0.00073	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TP53—uterine cancer	3.17e-05	0.000725	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.16e-05	0.000723	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—POLD1—uterine cancer	3.16e-05	0.000722	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.16e-05	0.000722	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FBXW7—uterine cancer	3.07e-05	0.000702	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.02e-05	0.000689	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKR1C1—uterine cancer	2.96e-05	0.000675	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.86e-05	0.000653	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKR1C1—uterine cancer	2.8e-05	0.00064	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—STK11—uterine cancer	2.69e-05	0.000614	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CCL2—uterine cancer	2.67e-05	0.000611	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—CTNNB1—uterine cancer	2.67e-05	0.000611	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RRM2—uterine cancer	2.64e-05	0.000602	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—DCN—uterine cancer	2.56e-05	0.000584	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SOCS3—uterine cancer	2.52e-05	0.000575	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—POLD1—uterine cancer	2.51e-05	0.000573	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PIK3CA—uterine cancer	2.43e-05	0.000555	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.43e-05	0.000555	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DCN—uterine cancer	2.43e-05	0.000554	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP11A1—uterine cancer	2.41e-05	0.00055	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN2B—uterine cancer	2.41e-05	0.00055	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKR1C1—uterine cancer	2.35e-05	0.000536	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1R—uterine cancer	2.34e-05	0.000534	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKR1C3—uterine cancer	2.28e-05	0.00052	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.23e-05	0.00051	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SMAD3—uterine cancer	2.2e-05	0.000502	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.16e-05	0.000493	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKR1C3—uterine cancer	2.16e-05	0.000493	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HMGA1—uterine cancer	2.1e-05	0.00048	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGFR2—uterine cancer	2.1e-05	0.000479	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RRM2—uterine cancer	2.09e-05	0.000478	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—DCN—uterine cancer	2.03e-05	0.000464	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AKT1—uterine cancer	1.99e-05	0.000454	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FBXW7—uterine cancer	1.92e-05	0.000439	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP11A1—uterine cancer	1.91e-05	0.000437	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.82e-05	0.000416	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKR1C3—uterine cancer	1.81e-05	0.000413	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—uterine cancer	1.79e-05	0.00041	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP19A1—uterine cancer	1.77e-05	0.000405	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—STK11—uterine cancer	1.77e-05	0.000405	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NRAS—uterine cancer	1.7e-05	0.000387	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.66e-05	0.00038	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.59e-05	0.000362	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CCL2—uterine cancer	1.58e-05	0.000361	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN2B—uterine cancer	1.51e-05	0.000344	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PIK3CA—uterine cancer	1.48e-05	0.000337	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—KRAS—uterine cancer	1.46e-05	0.000333	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—STK11—uterine cancer	1.41e-05	0.000321	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP19A1—uterine cancer	1.41e-05	0.000321	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SMAD3—uterine cancer	1.38e-05	0.000314	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PIK3CA—uterine cancer	1.34e-05	0.000306	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—uterine cancer	1.33e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.32e-05	0.000302	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ERBB2—uterine cancer	1.32e-05	0.000301	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGFR2—uterine cancer	1.31e-05	0.0003	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—uterine cancer	1.26e-05	0.000288	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.26e-05	0.000288	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRAS—uterine cancer	1.24e-05	0.000283	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CDKN1B—uterine cancer	1.22e-05	0.000279	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AKT1—uterine cancer	1.21e-05	0.000276	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.17e-05	0.000268	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CTNNB1—uterine cancer	1.15e-05	0.000263	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTEN—uterine cancer	1.12e-05	0.000256	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AKT1—uterine cancer	1.1e-05	0.00025	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EP300—uterine cancer	1.07e-05	0.000245	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—uterine cancer	1.06e-05	0.000242	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—VEGFA—uterine cancer	1.01e-05	0.000232	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NRAS—uterine cancer	1e-05	0.000229	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.32e-06	0.000213	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KRAS—uterine cancer	8.63e-06	0.000197	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ERBB2—uterine cancer	8.24e-06	0.000188	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PIK3CA—uterine cancer	7.93e-06	0.000181	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TP53—uterine cancer	7.67e-06	0.000175	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CDKN1B—uterine cancer	7.63e-06	0.000174	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PTEN—uterine cancer	7.41e-06	0.000169	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRAS—uterine cancer	7.33e-06	0.000167	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CTNNB1—uterine cancer	7.21e-06	0.000165	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—EP300—uterine cancer	7.07e-06	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PTEN—uterine cancer	7.03e-06	0.00016	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EP300—uterine cancer	6.7e-06	0.000153	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AKT1—uterine cancer	6.47e-06	0.000148	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NRAS—uterine cancer	6.27e-06	0.000143	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PTEN—uterine cancer	5.89e-06	0.000134	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—EP300—uterine cancer	5.61e-06	0.000128	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KRAS—uterine cancer	5.4e-06	0.000123	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PIK3CA—uterine cancer	5.23e-06	0.000119	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PIK3CA—uterine cancer	4.96e-06	0.000113	CbGpPWpGaD
Tolmetin—PTGS2—Disease—HRAS—uterine cancer	4.59e-06	0.000105	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AKT1—uterine cancer	4.27e-06	9.75e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PIK3CA—uterine cancer	4.15e-06	9.48e-05	CbGpPWpGaD
Tolmetin—PTGS2—Disease—AKT1—uterine cancer	4.05e-06	9.25e-05	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AKT1—uterine cancer	3.39e-06	7.74e-05	CbGpPWpGaD
